HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrike Schmidt Selected Research

Prostaglandins

1/2018State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrike Schmidt Research Topics

Disease

48Anorexia Nervosa
02/2024 - 06/2010
27Feeding and Eating Disorders (Eating Disorder)
01/2022 - 04/2010
21Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2021 - 05/2011
11Mental Disorders (Mental Disorder)
05/2024 - 01/2013
8Bulimia Nervosa
10/2023 - 10/2004
7Binge-Eating Disorder (Binge Eating Disorder)
10/2023 - 08/2015
7Schizophrenia (Dementia Praecox)
01/2021 - 01/2013
6Wounds and Injuries (Trauma)
12/2019 - 05/2011
5Neoplasms (Cancer)
02/2021 - 10/2003
4Obesity
01/2024 - 11/2017
4Bulimia (Binge Eating)
01/2022 - 04/2010
3Overweight
01/2024 - 10/2019
3Weight Gain
01/2021 - 01/2018
3Body Weight (Weight, Body)
01/2018 - 11/2013
3Hepatocellular Carcinoma (Hepatoma)
05/2007 - 09/2005
2Neoplasm Metastasis (Metastasis)
02/2021 - 09/2014
2Psychotic Disorders (Schizoaffective Disorder)
03/2020 - 01/2018
2Starvation
01/2017 - 01/2010
2Anxiety Disorders (Anxiety Disorder)
01/2015 - 01/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2023
1Opioid-Related Disorders (Opiate Addiction)
01/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2023
1Liver Diseases (Liver Disease)
01/2023
1COVID-19
02/2022
1Neuroinflammatory Diseases
09/2021
1Carcinoma (Carcinomatosis)
02/2021
1Colorectal Neoplasms (Colorectal Cancer)
02/2021
1Lung Neoplasms (Lung Cancer)
02/2021
1Body-Weight Trajectory
01/2021
1Emaciation
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Panic Disorder (Panic Attack)
10/2018

Drug/Important Bio-Agent (IBA)

9salicylhydroxamic acid (SHAM)IBA
01/2022 - 04/2010
7Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2005
7Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2013
6CytokinesIBA
01/2022 - 09/2014
5Antipsychotic Agents (Antipsychotics)IBA
02/2024 - 07/2013
4Messenger RNA (mRNA)IBA
10/2021 - 10/2018
4NeuropeptidesIBA
01/2021 - 05/2012
3mesoglycanIBA
02/2023 - 01/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 01/2021
3Tacrolimus Binding Proteins (FKBP)IBA
11/2021 - 01/2015
3InterleukinsIBA
10/2021 - 09/2014
3LipidsIBA
01/2019 - 07/2013
3Cytosine DeaminaseIBA
05/2007 - 09/2005
3ProdrugsIBA
05/2007 - 09/2005
3Flucytosine (Ancobon)FDA Link
05/2007 - 09/2005
2Olanzapine (Zyprexa)FDA Link
02/2024 - 01/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2021 - 01/2019
2Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2013
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019 - 11/2016
2Dopamine (Intropin)FDA LinkGeneric
01/2016 - 01/2016
2MicroRNAs (MicroRNA)IBA
06/2015 - 01/2013
2Fluoxetine (Prozac)FDA LinkGeneric
01/2013 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
05/2012 - 10/2003
2EnzymesIBA
11/2005 - 09/2005
1Alanine Transaminase (SGPT)IBA
01/2023
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2023
1Cocaine (Cocaine HCl)IBA
01/2023
1Heroin (Diamorphine)IBA
01/2023
1IronIBA
01/2023
1Lisdexamfetamine DimesylateFDA Link
11/2022
1tacrolimus binding protein 4 (FKBP52)IBA
11/2021
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2021
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2021
1Interleukin-12 (IL 12)IBA
08/2021
1Interleukin-7 (Interleukin 7)IBA
08/2021
1Small Interfering RNA (siRNA)IBA
02/2021
1Matrix Metalloproteinases (MMPs)IBA
02/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2021
1Cadherins (E-Cadherin)IBA
02/2021
1Oxytocin Receptors (Oxytocin Receptor)IBA
01/2021
1Oxytocin (Pitocin)FDA LinkGeneric
01/2021
1ElectrolytesIBA
05/2020
1PhytohemagglutininsIBA
11/2019
1InterferonsIBA
11/2019
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2019
1MelanocortinsIBA
01/2019
1Melanocyte-Stimulating Hormones (MSH)IBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1ProstaglandinsIBA
01/2018
1methyl nicotinateIBA
01/2018
1ORALIT (ORS)IBA
01/2018

Therapy/Procedure

28Therapeutics
05/2024 - 11/2005
15Transcranial Magnetic Stimulation
01/2022 - 04/2010
11Transcranial Direct Current Stimulation
02/2023 - 11/2013
4Caloric Restriction
01/2024 - 01/2020
4Deep Brain Stimulation
06/2021 - 11/2013
4Ambulatory Care (Outpatient Care)
11/2020 - 07/2014
3Medical Day Care (Partial Hospitalization)
01/2023 - 01/2011
3Secondary Prevention
01/2019 - 07/2013
2Drug Therapy (Chemotherapy)
01/2018 - 10/2004
2Neurofeedback
11/2017 - 11/2013
1Opiate Substitution Treatment
01/2023
1Patient Discharge
07/2022
1Patient Isolation
02/2022
1Aftercare (After-Treatment)
07/2020
1Cognitive Training
10/2019